Filing Details
- Accession Number:
- 0001415889-23-006300
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-05 17:00:12
- Reporting Period:
- 2023-04-03
- Accepted Time:
- 2023-04-05 17:00:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1551152 | Abbvie Inc. | ABBV | Pharmaceutical Preparations (2834) | 320375147 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1951400 | C Perry Siatis | 1 N. Waukegan Road North Chicago IL 60064 | Evp, Gc And Secretary | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2023-04-03 | 3,520 | $105.92 | 13,897 | No | 4 | M | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2023-04-03 | 3,520 | $160.00 | 10,377 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to buy) | Disposition | 2023-04-03 | 3,520 | $105.92 | 3,520 | $105.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,520 | 2022-02-18 | 2031-02-17 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.